Literature DB >> 15067126

Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages.

Yuki Kimura1, Nina Jones, Michael Klüppel, Masanori Hirashima, Kazunobu Tachibana, Jason B Cohn, Jeffrey L Wrana, Tony Pawson, Alan Bernstein.   

Abstract

Loss-of-function mutations in the murine dominant white spotting/c-kit locus affect a diverse array of biological processes and cell lineages and cause a range of phenotypes, including severe anemia, defective pigmentation, sterility, mast cell deficits, a lack of interstitial cells of Cajal, spatial learning memory deficits, and defects in peripheral nerve regeneration. Here we show that tyrosine residues 567 and 569 in the juxtamembrane (Jx) domain of the murine Kit receptor tyrosine kinase are crucial for the function of Kit in melanogenesis and mast cell development, but are dispensable for the normal development of erythroid, interstitial cells of Cajal and germ cells. Furthermore, adult mice lacking both tyrosines exhibit splenomegaly, dysregulation of B-cell and megakaryocyte development, and enlarged stomachs. Analysis of signal transduction events induced by the mutant receptors after ligand stimulation indicates that Jx tyrosine mutations diminish receptor autophosphorylation and selectively attenuate activation of extracellular signal-regulated kinase/mitogen-activated protein kinases. Together, these observations demonstrate that the Jx domain of Kit plays a cell-type specific regulatory role in vivo and illustrate how engineered mutations in Kit can be used to understand the complex biological and molecular events that result from activating a receptor tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067126      PMCID: PMC395915          DOI: 10.1073/pnas.0305363101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines.

Authors:  S Yokota; H Kiyoi; M Nakao; T Iwai; S Misawa; T Okuda; Y Sonoda; T Abe; K Kahsima; Y Matsuo; T Naoe
Journal:  Leukemia       Date:  1997-10       Impact factor: 11.528

Review 2.  Signaling through scaffold, anchoring, and adaptor proteins.

Authors:  T Pawson; J D Scott
Journal:  Science       Date:  1997-12-19       Impact factor: 47.728

3.  SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

Authors:  M Kozlowski; L Larose; F Lee; D M Le; R Rottapel; K A Siminovitch
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

4.  Developmental origin and Kit-dependent development of the interstitial cells of cajal in the mammalian small intestine.

Authors:  M Klüppel; J D Huizinga; J Malysz; A Bernstein
Journal:  Dev Dyn       Date:  1998-01       Impact factor: 3.780

5.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

6.  Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction.

Authors:  J Lennartsson; P Blume-Jensen; M Hermanson; E Pontén; M Carlberg; L Rönnstrand
Journal:  Oncogene       Date:  1999-09-30       Impact factor: 9.867

7.  A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors.

Authors:  M Nakahara; K Isozaki; S Hirota; J Miyagawa; N Hase-Sawada; M Taniguchi; T Nishida; S Kanayama; Y Kitamura; Y Shinomura; Y Matsuzawa
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

8.  Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos.

Authors:  J Partanen; L Schwartz; J Rossant
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

9.  Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1.

Authors:  U Lorenz; A D Bergemann; H N Steinberg; J G Flanagan; X Li; S J Galli; B G Neel
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Long-range genomic rearrangements upstream of Kit dysregulate the developmental pattern of Kit expression in W57 and Wbanded mice and interfere with distinct steps in melanocyte development.

Authors:  M Klüppel; D L Nagle; M Bucan; A Bernstein
Journal:  Development       Date:  1997-01       Impact factor: 6.868

View more
  25 in total

1.  Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD.

Authors:  Jennifer L Rocnik; Rachel Okabe; Jin-Chen Yu; Benjamin H Lee; Neill Giese; David P Schenkein; D Gary Gilliland
Journal:  Blood       Date:  2006-04-20       Impact factor: 22.113

2.  Green fluorescent protein transgene driven by Kit regulatory sequences is expressed in hematopoietic stem cells.

Authors:  Francesco Cerisoli; Letizia Cassinelli; Giuseppe Lamorte; Stefania Citterio; Francesca Bertolotti; Maria Cristina Magli; Sergio Ottolenghi
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

3.  KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors.

Authors:  Amie S Corbin; Thomas O'Hare; Zhimin Gu; Ira L Kraft; Anna M Eiring; Jamshid S Khorashad; Anthony D Pomicter; Tian Y Zhang; Christopher A Eide; Paul W Manley; Jorge E Cortes; Brian J Druker; Michael W Deininger
Journal:  Cancer Res       Date:  2013-07-25       Impact factor: 12.701

4.  Kit ligand cytoplasmic domain is essential for basolateral sorting in vivo and has roles in spermatogenesis and hematopoiesis.

Authors:  Shayu Deshpande; Valter Agosti; Katia Manova; Malcolm A S Moore; Matthew P Hardy; Peter Besmer
Journal:  Dev Biol       Date:  2009-10-27       Impact factor: 3.582

Review 5.  Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time.

Authors:  Katherine A Fantauzzo; Philippe Soriano
Journal:  Curr Top Dev Biol       Date:  2015-01-20       Impact factor: 4.897

6.  Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells.

Authors:  Lionel A Samayawardhena; Reuben Kapur; Andrew W B Craig
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

7.  The structural insights of stem cell factor receptor (c-Kit) interaction with tyrosine phosphatase-2 (Shp-2): an in silico analysis.

Authors:  Soumya Pati; Gangenahalli U Gurudutta; Om P Kalra; Asok Mukhopadhyay
Journal:  BMC Res Notes       Date:  2010-01-22

8.  Primordial germ cells and gastrointestinal stromal tumors respond distinctly to a cKit overactivating allele.

Authors:  Li Chen; Mehlika Faire; Michael D Kissner; Diana J Laird
Journal:  Hum Mol Genet       Date:  2012-10-16       Impact factor: 6.150

9.  Thrombopoietin inhibits murine mast cell differentiation.

Authors:  Fabrizio Martelli; Barbara Ghinassi; Rodolfo Lorenzini; Alessandro M Vannucchi; Rosa Alba Rana; Mitsuo Nishikawa; Sandra Partamian; Giovanni Migliaccio; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2008-02-14       Impact factor: 6.277

Review 10.  Recent discoveries in the genetics of melanoma and their therapeutic implications.

Authors:  Amélie Marquette; Martine Bagot; Armand Bensussan; Nicolas Dumaz
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-12-03       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.